关注
Jacek Jawien
Jacek Jawien
Profesor farmakologii, Uniwersytet Jagielloński
在 uj.edu.pl 的电子邮件经过验证
标题
引用次数
引用次数
年份
Mouse models of experimental atherosclerosis
J Jawien, P Nastalek, R Korbut
Journal of physiology and pharmacology 55 (3), 503-517, 2004
5602004
Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice
R Elhage, J Jawien, M Rudling, HG Ljunggren, K Takeda, S Akira, ...
Cardiovascular research 59 (1), 234-240, 2003
5062003
IL-18 accelerates atherosclerosis accompanied by elevation of IFN-γ and CXCL16 expression independently of T cells
C Tenger, A Sundborger, J Jawien, X Zhou
Arteriosclerosis, thrombosis, and vascular biology 25 (4), 791-796, 2005
2392005
Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice.
R Olszanecki, J Jawień, M Gajda, L Mateuszuk, A Gebska, ...
Journal of physiology and pharmacology: an official journal of the Polish …, 2005
2132005
Deleting TCRαβ+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice
R Elhage, P Gourdy, L Brouchet, J Jawien, MJ Fouque, C Fiévet, X Huc, ...
The American journal of pathology 165 (6), 2013-2018, 2004
1612004
Inhibition of five lipoxygenase activating protein (FLAP) by MK‐886 decreases atherosclerosis in apoE/LDLR‐double knockout mice
J Jawien, M Gajda, M Rudling, L Mateuszuk, R Olszanecki, TJ Guzik, ...
European journal of clinical investigation 36 (3), 141-146, 2006
1512006
Anti‐atherosclerotic effect of the angiotensin 1–7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis
DS Skiba, R Nosalski, TP Mikolajczyk, M Siedlinski, FJ Rios, ...
British Journal of Pharmacology 174 (22), 4055-4069, 2017
1252017
Ghrelin inhibits vascular superoxide production in spontaneously hypertensive rats
A Kawczynska-Drozdz, R Olszanecki, J Jawien, T Brzozowski, WW Pawlik, ...
American journal of hypertension 19 (7), 764-767, 2006
1162006
The role of an experimental model of atherosclerosis: apoE-knockout mice in developing new drugs against atherogenesis
J Jawien
Current pharmaceutical biotechnology 13 (13), 2435-2439, 2012
1152012
SUPEROXIDE DISMUTASE ACTIVITY AND EXPRESSION IN HUMAN
TJ Guzik, R Olszanecki, J Sadowski, B Kapelak, P Rudzinski, A Jopek, ...
Journal of Physiology and Pharmacology 56 (2), 313-323, 2005
752005
Inhibition of nuclear factor-kappaB attenuates artherosclerosis in apoE/LDLR-double knockout mice.
J Jawień, M Gajda, Ł Mateuszuk, R Olszanecki, A Jakubowski, ...
Journal of Physiology and Pharmacology: an Official Journal of the Polish …, 2005
732005
Endothelial action of thienopyridines and thienopyrimidinones in the isolated guinea pig heart
A Jakubowski, S Chlopicki, R Olszanecki, J Jawien, M Lomnicka, ...
Prostaglandins, leukotrienes and essential fatty acids 72 (2), 139-145, 2005
722005
Kaempferol, but not resveratrol inhibits angiotensin converting enzyme
R Olszanecki, B Bujak-Gizycka, J Madej, M Suski, PP Wolkow, J Jawien, ...
J Physiol Pharmacol 59 (2), 387-392, 2008
692008
Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice.
J Jawien, J Toton-Zuranska, M Gajda, A Niepsuj, A Gebska, K Kus, ...
atherosclerosis 1, 4, 2012
652012
Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice
J Jawien, G Csanyi, M Gajda, L Mateuszuk, M Lomnicka, R Korbut, ...
European journal of pharmacology 556 (1-3), 129-135, 2007
592007
AVE 0991—Angiotensin-(1-7) receptor agonist, inhibits atherogenesis in apoE-knockout mice
J Toton-Zuranska, M Gajda, G Pyka-Fosciak, K Kus, M Pawlowska, ...
Journal of Physiology and Pharmacology 61 (2), 181, 2010
542010
BAYx1005 attenuates atherosclerosis in apoE/LDLR-double knockout mice
J Jawien, M Gajda, R Olszanecki, R Korbut
Journal of Physiology and Pharmacology 58 (3), 583, 2007
512007
The current view on the role of leukotrienes in atherogenesis
J Jawien, R Korbut
Journal of Physiology and Pharmacology 61 (6), 647, 2010
462010
Hypercholesterolemia does not alter endothelial function in spontaneously hypertensive rats
B Lorkowska, M Bartus, M Franczyk, RB Kostogrys, J Jawien, ...
Journal of Pharmacology and Experimental Therapeutics 317 (3), 1019-1026, 2006
382006
Interactions between human platelets and eosinophils are mediated by selectin-P
J Jawieñ, S Chlopicki, RJ Gryglewski
Polish journal of pharmacology 54 (2), 157-160, 2002
332002
系统目前无法执行此操作,请稍后再试。
文章 1–20